|
STK35 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.320300E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.114560E-01 |
| Normal-vs-Stage2 |
3.165600E-02 |
| Normal-vs-Stage3 |
2.847800E-01 |
| Normal-vs-Stage4 |
3.273000E-01 |
| Stage1-vs-Stage2 |
1.285760E-01 |
| Stage1-vs-Stage3 |
7.353400E-01 |
| Stage1-vs-Stage4 |
7.719400E-01 |
| Stage2-vs-Stage3 |
1.059800E-01 |
| Stage2-vs-Stage4 |
1.176650E-01 |
| Stage3-vs-Stage4 |
9.911400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.568160E-02 |
| Normal-vs-AfricanAmerican |
1.471980E-01 |
| Normal-vs-Asian |
6.938800E-01 |
| Caucasian-vs-AfricanAmerican |
6.526000E-01 |
| Caucasian-vs-Asian |
2.141600E-01 |
| AfricanAmerican-vs-Asian |
2.410000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.620100E-02 |
| Normal-vs-Female |
6.194000E-02 |
| Male-vs-Female |
7.352200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.397780E-01 |
| Normal-vs-Age(41-60Yrs) |
6.686000E-02 |
| Normal-vs-Age(61-80Yrs) |
1.014360E-01 |
| Normal-vs-Age(81-100Yrs) |
3.144800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.806800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.112000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.313400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.448000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.463000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.933400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.388560E-01 |
| Classical-VS-Follicular |
2.2978999999923E-05 |
| Classical-VS-Other |
9.106800E-01 |
| Classical-VS-Normal |
1.240390E-03 |
| Tall-VS-Follicular |
1.879220E-01 |
| Tall-VS-Other |
5.595200E-01 |
| Tall-VS-Normal |
5.560000E-01 |
| Follicular-VS-Other |
1.791800E-01 |
| Follicular-VS-Normal |
3.248600E-01 |
| Other-VS-Normal |
4.449800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.429590E-01 |
| Normal-vs-N1 |
3.151000E-01 |
| N0-vs-N1 |
8.917600E-01 |
|
|
